Background: Magnolia officinalis Rehder and EH Wilson (M. officinalis) are traditional Chinese medicines widely used for gastrointestinal (GI) tract motility disorder in Asian countries. We investigated the effects of an ethanol extract of M. officinalis (MOE) on the pacemaker potentials of cultured interstitial cells of Cajal (ICCs) in vitro and its effects on GI motor functions in vivo. Methods: We isolated ICCs from small intestines, and the whole-cell patchclamp configuration was used to record the pacemaker potentials in cultured ICCs in vitro. Both gastric emptying (GE) and intestinal transit rates (ITRs) were investigated in normal and GI motility dysfunction (GMD) mice models in vivo. Results: MOE depolarized ICC pacemaker potentials dose-dependently. Pretreatment with methoctramine (a muscarinic M 2 receptor antagonist) and 4-DAMP (a muscarinic M 3 receptor antagonist) inhibited the effects of MOE on the pacemaker potential relative to treatment with MOE alone. In addition, MOE depolarized pacemaker potentials after pretreatment with Y25130 (a 5-HT 3 receptor antagonist), GR113808 (a 5-HT 4 receptor antagonist) or SB269970 (a 5-HT 7 receptor antagonist). However, pretreatment with RS39604 (a 5-HT 4 receptor antagonist) blocked MOE-induced pacemaker potential depolarizations. Intracellular GDPβS inhibited MOE-induced pacemaker potential depolarization, as did pretreatment with Ca 2+ free solution or thapsigargin. In normal mice, the GE and ITR values were significantly and dose-dependently increased by MOE. In loperamide- 
Introduction
Magnolia officinalis Rehder and EH Wilson (M. officinalis) have been widely used in traditional Chinese medicine to treat various symptoms, including those of anxiety, stress, antibacterial diseases, allergic diseases and oxidative stress [1] [2] [3] [4] [5] [6] . In addition, M. officinalis is an herb with a large variety of uses for the remedy of gastrointestinal (GI) disorders such as dyspepsia, abdominal distention and constipation [7] [8] [9] [10] [11] [12] [13] . M. officinalis has been shown to improve gastrointestinal peristaltic activity in mice [12] , as well as to have anti-spasmodic effects in guinea pigs [8] . Moreover, M. officinalis has beneficial effects on atropine-induced GI tract dysmotility that are mediated by activation of the c-kit/stem cell factor (SCF) pathway in interstitial cells of Cajal (ICCs) [11] . In addition, Jeong et al. [14] suggested that the main component of M. officinalis, magnolol, showed the contractile activity in the rat GI tract. However, Zhang et al. [13] suggested that magnolol inhibited the contractions of distal colonic segments by inhibiting L-type Ca 2+ channels in rat. ICCs are the pacemaker cells in the GI tract that contribute to normal GI motility by generating electrical slow waves [15] [16] [17] . Damage to ICCs or reductions in ICC numbers have been described in many GI motility disorders [18, 19] . Therefore, it is important to identify the mechanisms underlying ICC pacemaker activity to understand GI function. However, no scientific studies conducted to date have presented evidence of any relationship between M. officinalis and ICCs.
In the present study, we investigated the effects of an ethanol extract of M. officinalis (MOE) on the pacemaker potentials of cultured ICCs in vitro and the effects of MOE on GI motor functions in vivo under the normal and abnormal conditions by determining the gastric emptying (GE) and the intestinal transit rates (ITR) in mice.
Materials and Methods

Preparation of the sample and HPLC Analysis
The dried bark of Magnolia officinalis was purchased from Kapdang Co. (Seoul, Korea). Honokiol and magnolol were purchased from Sigma-Aldrich (St. Louis, MO, USA). The plant samples were confirmed by Dr. Yun Tai Kim and a voucher specimen (#NP-1601) was deposited with the research group of innovative special food, Korea Food Research Institute. Dried bark of M. officinalis (600 g) was extracted with 70% ethanol (6000 mL) for 1 hour at 20°C and the process was repeated once. The extracts were combined, then passed through a membrane filter (0.45 µm; Millipore, Billerica, MA, USA), after which the solvents were removed by rotary evaporation (N-21NS, EYELA, Tokyo, Japan). The remaining extracts were then freezedried, yielding about 1.47% of the dried bark weight (w/w). The freeze-dried extract powder (100 mg) was subsequently dissolved in 10 mL of methanol for one hour, then filtered through a 0.45 µm RC-membrane filter (Sartorius Stedim, Goettingen, Germany) and diluted prior to injection (20 µL) into the HPLC system. Analytical HPLC was conducted using a Jasco HPLC system (Jasco, Hachioji, Tokyo, Japan) comprising a PU-980 pump, an AS-950-10 autosampler, and a MD-2010 Plus multi-wavelength detector. Chromatic separation was conducted at 30°C on a Waters Symmetry ® C18 (4.6 mm × 250 mm, particle size 5 μm) column, after which samples were eluted using a mobile phase composed of 0.4% formic acid and acetonitrile (35: ) of each standard curve were automatically determined using a Jasco HPLC system. The regression equations of honokiol and magnolol were y=4228.1899x + 18613.9165 with an R 2 of 0.99959 and y=5766.4127x -13822.8914 with an R 2 of 1, respectively, indicating that a high linear correlation was achieved for all standard curves. The concentrations of honokiol and magnolol were determined to be 29.417 ± 0.303 mg/g and 56.609 ± 1.447 mg/g based on the peak area in the chromatogram and the regression equation (Fig. 1) .
Ethics
Animal care and experiments were conducted in accordance with the guidelines issued by the Institutional Animal Care and Use Committee (IACUC) at Pusan National University (Busan, Republic of Korea; Approval no. PNU-2015-1036) and those issued by the National Institute of Health Guide for the Care and Use of Laboratory Animals.
Preparation of ICC and ICC clusters ICR mice (Samtako Bio Korea Co., Ltd., Osan, Republic of Korea; 3-7 days old; weighing 1.9-2.2 g) of either sex were used to examine the effects of MOE on ICC pacemaker potentials. Animals were maintained under controlled conditions (21 ± 3°C, relative humidity (RH) 50 ± 6%, lights on 6 a.m.-6 p.m.). Small intestines were removed and opened along the mesenteric border. Luminal contents were removed using Krebs-Ringer bicarbonate solution. Mucosae were then removed by sharp dissection, and small tissue strips of intestine muscle were then equilibrated for 30 min in Ca
2+
-free Hank's solution (containing (in mM); KCl 5.36, NaCl 125, NaOH 0.34, Na 2 HCO 3 0.44, glucose 10, sucrose 2.9 and HEPES 11; pH 7.4). Cells were then dispersed in an enzyme solution containing 1.7 mg ml -1 collagenase (Worthington Biochemical, Lakewood, NJ, USA), 2.5 mg ml -1 bovine serum albumin (Sigma-Aldrich, St. Louis, MO, USA), 3.0 mg ml -1 trypsin inhibitor (Sigma-Aldrich, St. Louis, MO, USA), and 0.60 mg ml -1 ATP (Sigma-Aldrich, St. Louis, MO, USA). Next, cells were cultured at 37°C in a 95% O 2 -5% CO 2 incubator in smooth muscle growth medium (SMGM) (Clonetics, San Diego, CA, USA) supplemented with 2% antibiotics/antimycotics (Gibco, Grand Island, NY, USA) and 5 ng ml -1 of murine stem cell factor (SCF) (Sigma-Aldrich, St. Louis, MO, USA). At first, ICCs were cultured only for <12 h and we checked using anti-c-kit antibody immunologically (eBioscience, San Diego, CA, USA) at a dilution of 1:50 for 20 min [20] . However, in this case, we could not experiment with patch-clamp methods because of bad state of ICCs. Therefore, because ICCs differed morphologically from other cell types in cultures, they were identified by phase contrast microscopy. The morphology of ICCs was spindle-shaped, with several branches emanating from a central soma, and connected with neighboring cells, showing networks. The ICCs in the cultures were morphologically distinct from the other cells. Therefore, the patchclamp technique was tested from ICCs that showed the network-like structures in cultures and after that, we identified c-Kit protein by immunostaining with anti c-kit antibody [21] . In this case, almost all cells are c-kit positive and at this time, spontaneous rhythmicity was routinely recorded from cultured ICC under current-clamp conditions and ICC within networks had a more robust electrical rhythmicity, and tissue-like spontaneous slow waves were recorded from these cells [22] .
Patch-clamp experiments
We used whole-cell patch clamp methods to record the effects of MOE on ICC pacemaker potentials. The physiological salt solution used to bathe cultured ICC clusters contained (in mM): KCl 5, NaCl 135, CaCl 2 2, glucose 10, MgCl 2 1.2, and HEPES 10 (adjusted to pH 7.4 with NaOH). The pipette solution used to examine pacemaker potentials contained (in mM): KCl 140, MgCl 2 5, K 2 ATP 2.7, NaGTP 0.1, creatine phosphate disodium 2.5, HEPES 5, and EGTA 0.1 (adjusted to pH 7.2 with KOH). Patch-clamp techniques were conducted using Axopatch I-D and Axopatch 200B amplifiers (Axon Instruments, Foster, CA, USA). Command pulses were applied using an IBM-compatible personal computer and pClamp software (version 6.1 and version 10.0; Axon Instruments, Foster, CA, USA). Data were filtered at 5 kHz and displayed on an oscilloscope, a computer monitor, and/or on a pen recorder (Gould 2200) (Gould, Valley View, OH, USA). Results were analyzed using pClamp and Origin software (version 6.0) (Microcal, Northampton, MA, USA). All experiments were performed at 30°C-32°C.
Evaluation of gastric emptying (GE)
GE was performed by administering 0.05% (w/v) phenol red solution 30 min after administering MOE. Mice were sacrificed 20 min later, after which their stomachs were immediately removed, cut into several pieces in 5 mL of 0.01 N NaOH, homogenized, and treated with 0.2 mL of 20% trichloroacetic acid per mL of homogenate. Mixtures were then centrifuged for 10 min at 1050 g, after which the supernatants (0.05 mL) were added to 0.5 N NaOH (0.2 mL). GE (%) was calculated using 100-(A/B)×100, where A is the test stomach absorbance (560 nm) and B is the control stomach absorbance (560 nm) immediately after phenol red administration.
Measurement of intestinal transit rates (ITR%) using Evans blue
We used Evans blue solution (5%, w/v) to determine the ITR% of MOE in vivo. Evans blue solution was administered (0.1 ml/kg of body weight; i.g.) through an orogastric tube 30 min after administering MOE i.g. to normal ICR mice. Animals were sacrificed 30 min after Evans blue administration, and the intestinal transit distances were determined by measuring the distance the Evans blue had migrated in the intestine (from the pylorus to its most distal point).
Induction of GI motility dysfunction (GMD) in mice
Two experimental GMD models, an acetic acid (AA)-induced peritoneal irritation (PI) and a streptozotocin (STZ)-induced diabetic mouse model, were used. For the AA model, PI was induced by administering AA to ICR mice 30 min after the i.g. administration of MOE by injecting AA (0.5 %, w/v, in saline) intraperitoneally (i.p.) at 10 ml/kg. After injecting AA, mice were allowed to recover for 30 min. For the STZ-induced diabetic mouse model, male ICR mice weighing 20-25 g aged 4-5 weeks were used. Mice were randomly allocated to two groups, a control group or a diabetic group. To produce diabetes, mice were fasted overnight, then administered STZ (Sigma-Aldrich, St. Louis, MO) solution i.p. on the following day. Fresh STZ solution was prepared in 0.1M/L ice-cold citrate buffer (pH=4.0) and administered at 200 mg/kg body weight [23] . Control mice were administered the same volume of 0.1 M/L citrate buffer i.p. Two months after STZ injection, blood was withdrawn from the tail vein after an 8 h fast and blood glucose concentrations were measured using a ONE-TOUCH Select Simple kit (Johnson & Johnson Medical Company). Diabetes was defined as a blood glucose level >16 mM. No mortality occurred during the study period and no mice recovered from STZ-induced diabetes. Drugs Y25130, RS39604, SB269970, GR113808, loperamide and cisplatin were purchased from Tocris Bioscience (Bristol, United Kingdom), while methoctramine, 4-DAMP, GDP-β-S, thapsigargin, mosapride and domperidone were obtained from Sigma-Aldrich (St. Louis, MO, USA). For stock solutions, all drugs were dissolved in distilled water (DW) or dimethylsulfoxide (DMSO) and stored at -20°C. The final concentration of DMSO in the bath solution was always <0.1%, and we confirmed that it did not affect the results at this concentration. Furthermore, the additions of these chemicals did not alter bath solution pH.
Statistical analysis
Results are expressed as the means ± SEMs. N values refer to the numbers of cells used in the experiments. For multiple comparison analysis, we used one-way ANOVA with Bonferroni's post hoc comparison. For statistical analyses, we used Prism 6.0 (GraphPad Software Inc., La Jolla, CA, USA) and Origin version 8.0 (OriginLab Corporation, Northampton, MA, USA). P values of <0.05 were considered statistically significant.
Results
Functional components of MOE
The presence of magnolol and honokiol in MOE was established by HPLC, and their levels were quantified using calibration curves obtained from purchased standards (Fig. 1) . Validation of the method used confirmed its reliability and stability.
Effects of MOE on the pacemaker potentials in ICCs
Using the whole cell patch clamp technique, we investigated the characters of cell clusters. Cell clusters formed network-like structures after culture for <12 h and were viable as demonstrated by the generation of spontaneous rhythmic contractions. Under
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Cellular Physiology and Biochemistry current clamp mode (I=0), ICCs generated pacemaker potentials ( Fig. 2) with a mean resting membrane potential of -58.2 ± 1.3 mV and a mean amplitude of 23.6 ± 0.6 mV. We initially examined the effects of MOE on the pacemaker potentials of ICCs. MOE (1-10 mg/ ml) depolarized pacemaker potentials and decreased their amplitudes in a concentrationdependent manner ( Fig. 2A-2C ). In the presence of MOE, the mean degrees of depolarization were 5.5 ± 0.4 mV at 1 mg/ml, 11.2 ± 0.8 mV at 5 mg/ml, and 25.1 ± 0.9 mV at 10 mg/ml (Fig.  2D , n = 15), while the mean amplitudes were 17.4 ± 0.8 mV at 1 mg/ml, 4.8 ± 1.2 mV at 5 mg/ml, and 1.5 ± 0.4 mV at 10 mg/ml (Fig. 2E, n = 15) . Summarized values and a bar graph 
showing the effects of MOE on pacemaker potentials are provided in Figs. 2D and 2E . Overall, the results show that MOE depolarizes ICC pacemaker potentials dose-dependently.
Identification of MOE-target receptor subtypes in ICCs.
Muscarinic receptors mediate GI smooth muscle cell membrane depolarizations [24, 25] , and isolated ICCs express muscarinic M 2 and M 3 receptor subtypes in the murine small intestine [26] . Moreover, 5-HT receptors are involved in the GI tract motility [27] , and previous studies have shown seven 5-HT receptor subtypes are expressed in the GI tract, but only murine small intestine ICCs express three of these receptors (5-HT 3 , 5-HT 4 , and 5-HT 7 ) [28, 29] . Therefore, we used the muscarinic or serotonergic receptor subtype antagonists to determine which receptor subtypes are involved in MOE-induced pacemaker potential depolarizations. First, ICCs were exposed to the muscarinic M 2 receptor antagonist, methoctramine (10 μM for 5 min), or the muscarinic M 3 receptor antagonist, 4-DAMP (10 μM for 5 min), respectively. Methoctramine or 4-DAMP alone did not affect the pacemaker potentials, and pretreatment with methoctramine or 4-DAMP did not completely inhibit the MOE-induced effects ( Fig. 3A and 3B ). MOE-induced pacemaker potential depolarization was 6.5 ± 0.4 mV in the presence of methoctramine ( Fig. 3A ; n = 9) and 3.3 ± 0.6 mV in 4-DAMP ( Fig. 3B ; n = 7). However, when we applied these antagonists together, MOE-induced effects were completely blocked ( Fig. 3C and 3D ). In addition, various 5-HT receptor antagonists were also pretreated in ICCs, respectively. Y25130 (a 5-HT 3 receptor antagonist), RS39604 (a 5-HT 4 receptor antagonist), GR113808 (a 5-HT 4 receptor antagonist), or SB269970 (a 5-HT 7 receptor antagonist) were pretreated in ICCs at 10 μM for 5 min, respectively, and after that, MOE was added. In case of pretreatment with RS39604 in ICCs, the MOE-induced effects were blocked, and MOE-induced pacemaker potential depolarization was 5.1 ± 0.9 mV in the presence of RS39604 ( Fig. 4B ; n = 6). However, in case of pretreatment with Y25130, SB269970 or GR113808, MOE depolarized ICCs resting membrane pacemaker potential (Fig. 4A, 4C and 4D) . The MOE-induced pacemaker potential depolarization was 11.6 ± 0.6 mV in the presence of Y25130 ( Fig. 4A ; n = 6), 10.7 ± 0.5 mV in GR113808 ( Fig. 4C ; n = 7) and 10.2 ± 0.3 mV in SB269970 ( Fig. 4D ; n = 5). These results suggest that MOE affects ICC pacemaker potentials through the M 2 and M 3 receptors. 
Involvement of G protein in MOE-induced pacemaker potential depolarization in ICCs
To investigate if G-proteins are required for MOE-induced pacemaker potential depolarization, we used GDP-β-S, which permanently inactivates G-protein binding proteins [30, 31] . When GDP-β-S (1 mM) was applied, MOE (5 mg/ml) only caused slight pacemaker potential depolarization (2.5 ± 0.5 mV, n = 6; Fig. 5 ). These results indicate that G-protein is involved in MOE-induced ICC pacemaker potential depolarization.
Effects of an external Ca 2+ -free solution and endoplasmic reticulum Ca 2+ -ATPase inhibitor on MOE-induced pacemaker potential depolarization in ICCs
Internal and external Ca 2+ have important roles in GI motility regulations [32] . To investigate the roles of internal and external Ca 2+ in MOE-induced pacemaker potential -free solution (Fig. 6A) or thapsigargin (Fig. 6B ) abolished pacemaker potentials, and MOE did not induce pacemaker potential depolarizations under these conditions (n=7; respectively, Fig. 6 ). These results indicate that MOE-induced pacemaker potential depolarization is dependent on internal and external Ca 2+ regulation.
Effects of MOE on GE in normal mice
In normal mice, MOE (1 g/kg)-treated groups showed significantly higher GE (%) values than non-treated controls [GE values for MOE at 0.01, 0.1 or 1 g/kg were 51.4 ± 1.2%, 51.8 ± 1.7% and 62.5 ± 1.3% (p < 0.001), respectively; Fig. 7A ]. Additionally, MOE at 1 g/kg had effects similar to those of mosapride (5 mg/kg) [61.8 ± 1.9% (p < 0.001)] and domperidone (Fig. 2A) . We next examined loperamide-induced and cisplatin-induced GE delay models to determine if MOE could increase GE in these abnormally depressed GE models. In the loperamide-induced GE delay model, the mean GE was lower than normal [46.8 ± 4.1% (p < 0.001); Fig. 7B ], and this decrease was inhibited by MOE at 1 g/kg [GE values for MOE at 0.01, 0.1 and 1 g/kg were 44.5 ± 1.5%, 47.6 ± 1.9% and 53.5 ± 0.9% (p < 0.001), respectively; Fig. 7B ]. The effects of MOE at 1 g/kg were comparable to those of mosapride (5 mg/kg) [53.5 ± 1.1% (p < 0.001)] or domperidone (5 mg/kg) [54.6 ± 0.9% (p < 0.001)] (Fig. 7B ). In addition, decreased GE was also inhibited by MOE (0.1 or 1 g/kg) in the cisplatin-induced GE delay model, with GE values at MOE 0.01, 0.1 and 1 g/ kg of 47.2 ± 1.5%, 51.6 ± 1.6% (p < 0.001) and 53.2 ± 1.5% (p < 0.001), respectively, being observed (Fig. 7C) . The effects of MOE at 1 g/kg were comparable to those of mosapride (5 mg/kg) [54.6 ± 1.1% (p < 0.001)] or domperidone (5 mg/kg) [55.1 ± 1.4% (p < 0.001)] (Fig.  7C) .
Effects of MOE on ITR% in normal and GMD mice
The mean ITR% for Evans blue after 30 min in normal mice was 46.5 ± 0.9% (Fig. 8A) . PF (1 g/kg) , which has been demonstrated to have prokinetic activity in the GI tract [33] , significantly increased ITR% [67.8 ± 1.1% (p < 0.001)]. The MOE increased ITR% dosedependently [ITR% values at 0.01, 0.1 and 1 g/kg were 54.6 ± 0.6% (p < 0.001), 60.5 ± 1.2% (p < 0.001) and 68.5 ± 1.1% (p < 0.001), respectively; Fig. 8A ]. Loperamide decreased 
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ITR%, which is consistent with the results of previous studies [34] , and MOE inhibited this loperamide-induced ITR% decrease [ITR% for loperamide was 34.4 ± 1.5%, while it was 46.1 ± 0.8% for loperamide with MOE (p < 0.001); Fig. 8A ]. To examine the effects of MOE on GMD models, we used AA and STZ-induced diabetic mouse models of experimental GMD. The AA mouse model showed a significant ITR% decrease [to 32.6 ± 1.2% vs 44.4 ± 0.7% for normal controls; p < 0.001; Fig. 8B ]. However, intragastric treatment with MOE at 0.01, 0.1, or 1 g/kg significantly inhibited this reduction [to 33.3 ± 1.1%, 40.0 ± 2.0 % (p < 0.001) and 44.1 ± 0.9% (p < 0.001), respectively; Fig. 8B ]. In addition, loperamide decreased ITR% in AA mice and MOE reduced this decrease (Fig. 8B) . STZ-induced diabetic mice also showed significant ITR% reduction (to 28.5 ± 1.3%; Fig. 8C ), which was also significantly inhibited by MOE at 0.01, 0.1 or 1 g/kg [to 31.9 ± 1.3% (p < 0.001), 37.0 ± 1.4% (p < 0.001) and 43.1 ± 0.7% (p < 0.001), respectively; Fig. 8C ]. In addition, loperamide decreased ITR% in STZ-induced diabetic mice, while MOE reduced this decrease (Fig. 8C) . Taken together, these results indicate that MOE increased ITR% in mice with GMD.
Discussion
The present study was conducted to investigate the effects of ethanol extracts of M. officinalis on GI motor function. M. officinalis has been widely used for the remedy of a variety of digestive dysfunctions, and of that, a few studies have reported their effects on GI function [7] [8] [9] [10] [11] [12] [13] .
In the present study, we found that MOE dose-dependently depolarized ICC pacemaker potentials through M 2 and M 3 receptors via internal and external Ca 2+ regulation through G protein pathways in vitro and that MOE increased GE and ITRs in normal and GMD mouse models in vivo. Methoctramine or 4-DAMP inhibited the effects of MOE on pacemaker potential when compared with MOE treatment alone (Fig. 3) . In addition, after pretreatment with Y25130, GR113803 or SB269970, MOE depolarized ICCs pacemaker potential. However, the pretreatment with RS39604 blocked the MOE-induced effects (Fig. 4) . Both Intracellular GDPβS and in case of pretreatment with Ca 2+ free solution or thapsigargin inhibited MOEinduced effects (Fig. 5 and 6 ). In normal mice, the GE and ITR values increased significantly and dose-dependently in response to MOE (Fig. 7 and 8) . In loperamide-and cisplatininduced GE delay models, MOE administration reversed the GE deficits (Fig. 7) . The ITRs of the GMD mice were significantly reduced relative to those of normal mice, which were significantly and dose-dependently reversed by MOE (Fig. 8) . Therefore, MOE showed a potent gastroprokinetic activity in both normal and abnormal mice.
The main components of M. officinalis are magnolol and honokiol, show a variety of biological functions. The biological activity of these compounds appears to be due to the presence of hydroxyl and allylic groups on a biphenolic moiety [4, 35, 36] . Several previous studies have reported the effects of M. officinalis on the GI tract. M. officinalis inhibited the contractile activity of gastric fundus strips in rats [12] and it inhibited acetylcholine-induced contraction in guinea pig isolated ileum [8] . Also, Zhang et al. [13] suggested that magnolol inhibited the contractions of distal colonic segments by inhibiting L-type Ca 2+ channels. However, another studies suggested that M. officinalis improved atropine and L-Arg induced GI motility dysfunction and enhanced the intestinal propulsion rate by recording the time of excreting carbo medicinalis [10] . In addition, Tian et al. [11] . suggested that atropine impaired the SCF/c-kit signaling pathways in ICCs and M. officinalis recovered the atropine-induced gastric dysmotility in rats. They investigated the M. officinalis effects in atropine-related GI dysmotility in rats in vivo [10, 11] and they checked the molecular (c-kit and SCF) and enzyme (gastrin, motilin, somatostatin, and substance P) levels in GI whole segments tissue [10, 11] . Also, Jeong et al. [14] also suggested that magnolol showed contractile activity in the rat GI tract. GI motility patterns are highly integrated behaviours requiring coordination between smooth muscle cells and utilizing regulatory inputs from ICCs, neurons, and endocrine and immune cells [37] . In this study, we investigated the effects M. officinalis on only ICCs. MOEinduced effects were not completely blocked by either methoctramine (a muscarinic M 2 Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry antagonist) or by 4-DAMP (a muscarinic M 3 antagonist) ( Fig. 3A and 3B ). However, when we applied these antagonists together, MOE-induced effects were completely blocked (Fig.  3C ). In addition, in case of pretreatment with Y25130 (a 5-HT 3 antagonist), GR113808 (a 5-HT 4 antagonist) or SB269970 (a 5-HT 7 antagonist), MOE-induced effects have no changed (Fig. 4A, 4C and 4D) . However, in case of pretreatment with another type 5-HT 4 antagonist, RS39604, the MOE-induced effects were blocked (Fig. 4B) . Therefore, we think that the MOEinduced effects on 5-HT 4 receptors by RS39604 may be non-specific effects and these results suggest that MOE affects ICC pacemaker potentials through the M 2 and M 3 receptors. Smooth muscle cells of the GI tract express muscarinic receptors and binding of ACh activates nonselective cation channels in these cells [38] [39] [40] . These channels are encoded by canonical transient receptor potential (TRPC) channels, types 4 and 6 (i.e. TRPC4 and TRPC6) [41, 42] . The small intestine ICCs have also been shown to express both M 2 and M 3 receptors [23, 43] . Carbachol (CCh) induced the pacemaker potential depolarizations of ICCs [44] and we think that MOE have similar effects with CCh on ICCs. CCh induced effects on ICCs were regulated by G-protein via internal and external Ca 2+ modulation [44] like MOE-induced effects. Therefore, we think that in ICCs, TRPC4 and TRPC6 channels may be involved in MOEinduced muscarinic receptor activation via G protein. These mechanisms may be responsible for the MOE-induced ICCs depolarization, and thereby accelerate intestinal motility in vivo. Therefore, although the results have been inconsistent, inhibitory effect or enhancing effect, in our hands, M. officinalis exerted an enhancing effect on GI motilities as references 10, 11, and 14.
ICCs act as pacemaker cells in GI motility function [15-17, 37, 45] . Therefore, they play a role in the generation and propagation of electrical properties in smooth muscles [15, 46] . ICCs have also been shown to be involved in neurotransmission [32, 37, [47] [48] [49] . Therefore, we believe that M. officinalis act on smooth muscle cells or enteric neurons through ICCs in the GI tract. Because many GI motility disorders have been associated with ICC abnormalities, it is extremely important to understand the mechanisms underlying pacemaker activity and ICC excitability [50] .
In summary, the results of the present study show that (1) MOE concentration-dependently depolarizes the pacemaker potentials in ICCs; (2) MOE affects ICC pacemaker potentials through the M 2 and M 3 receptors; (3) G-protein is involved in MOE-induced ICC pacemaker potential depolarizations; (4) MOE-induced pacemaker potential depolarization is dependent on internal and external Ca 2+ regulation; and (5) MOE shows potent gastroprokinetic activity in both normal and abnormal mice. Taken together, these results indicate that M. officinalis has the potential for development of a gastroprokinetic agent for use in GI motility function.
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